Insulet Corp Files 2024 10-K

Ticker: PODD · Form: 10-K · Filed: 2025-02-21T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, financials, medical-devices

TL;DR

INSULET 2024 10-K FILED: DEBT, ASSETS, LIABILITIES DETAILED.

AI Summary

Insulet Corporation filed its 2024 10-K on February 21, 2025, reporting its fiscal year ending December 31, 2024. The company, a leader in surgical and medical instruments, is incorporated in Delaware and headquartered in Acton, MA. Key financial reporting elements include long-term debt, property, plant, and equipment, and various current and noncurrent liabilities and assets.

Why It Matters

This filing provides a comprehensive overview of Insulet's financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess performance and future outlook.

Risk Assessment

Risk Level: medium — The filing details significant financial components like long-term debt and various assets/liabilities, indicating a complex financial structure that warrants careful review.

Key Numbers

Key Players & Entities

FAQ

What was Insulet Corporation's total revenue for the fiscal year ending December 31, 2024?

The provided filing snippet does not contain specific revenue figures for the fiscal year ending December 31, 2024. It focuses on financial statement line items and reporting structure.

What is the amount of Insulet Corporation's long-term debt as of December 31, 2024?

The filing indicates 'LongTermDebtCurrent' and 'LongTermDebtAndCapitalLeaseObligations' as reporting categories, but specific dollar amounts are not detailed in this excerpt.

When was Insulet Corporation incorporated?

Insulet Corporation is incorporated in Delaware (DE), as indicated in the filing.

What are the primary business segments of Insulet Corporation?

The filing identifies Insulet Corporation's Standard Industrial Classification (SIC) code as 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.

What is the company's primary contact phone number?

The business phone number listed for Insulet Corporation is 978-600-7000.

From the Filing

0001145197-25-000007.txt : 20250221 0001145197-25-000007.hdr.sgml : 20250221 20250220173654 ACCESSION NUMBER: 0001145197-25-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 153 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25647530 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 10-K 1 podd-20241231.htm 10-K podd-20241231 false 2024 FY 0001145197 http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member 1 P3Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#LongTermDebtCurrent http://fasb.org/us-gaap/2024#LongTermDebtCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations 0.0044105 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense 301 iso4217:USD xbrli:shares iso4217:USD xbrli:shares podd:segment xbrli:pure podd:notice podd:loans podd:day iso4217:USD podd:option 0001145197 2024-01-01 2024-12-31 0001145197 2024-06-30 0001145197 2025-02-13 0001145197 2024-12-31 0001145197 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-12-31 0001145197 us-gaap:NonrelatedPartyMember 2023-12-31 0001145197 us-gaap:RelatedPartyMember 2024-12-31 0001145197 us-gaap:RelatedPartyMember 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-01-01 2024-12-31 0001145197 us-gaap:NonrelatedPartyMember 2023-01-01 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2022-01-01 2022-12-31 0001145197 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0001145197 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001145197 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001145197 2023-01-01 2023-12-31 0001145197 2022-01-01 2022-12-31 0001145197 us-gaap:CommonStockMember 2021-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001145197 us-gaap:RetainedEarningsMember 2021-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001145197 2021-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2022-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2022-12-31 0001145197 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001145197 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001145197 us-gaap:CommonStockMember 2022-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001145197 us-gaap:RetainedEarningsMember 2022-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001145197 2022-12-31 0001145197 us-gaap:CommonStockMember 2

View on Read The Filing